Clinical Oncology Next Generation Sequencing (NGS) Market Report

China Clinical Oncology Next Generation Sequencing (NGS) Industry Market Research Report 2023-2029

  • POSTDATE：Sep 17, 2023
  • PAGES：166
  • REPORT CODE：GMM1805151
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Clinical Oncology Next Generation Sequencing (NGS) industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • DNASTAR

    • Genomatix Software

    • BGI

    • Roche

    • Paradigm

    • Qiagen

    • Myriad Genetics

    • Foundation Medicine

    • Biomatters

    • GATC Biotech

    • CLC Bio

    • Caris Life Sciences

    • Oxford Nanopore Technologies

    • Agilent Technologies

    • Knome

    • Exosome Diagnostics

    • Perkin Elmer

    • Life Technologies

    • Illumina

    • Pacific Bioscience

    By Type:

    • Sequencing

    • NGS Pre-Sequencing

    • NGS Data Analysis

    • Primary, Secondary & Tertiary Data Analysis

    By Application:

    • Pharma & Biotech Entities

    • Hospitals & Clinics

    • Academic & Clinical Research

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Clinical Oncology Next Generation Sequencing (NGS) Market Overview 2018-2029

    • 1.1 China Clinical Oncology Next Generation Sequencing (NGS) Industry Development Overview

    • 1.2 China Clinical Oncology Next Generation Sequencing (NGS) Industry Development History

    • 1.3 China Clinical Oncology Next Generation Sequencing (NGS) Industry Market Size (2018-2029)

    • 1.4 China Clinical Oncology Next Generation Sequencing (NGS) Market Analysis by Type from Production Side

      • 1.4.1 China Clinical Oncology Next Generation Sequencing (NGS) Production Volume, Production Value and Growth Rate of Sequencing (2018-2029)

      • 1.4.2 China Clinical Oncology Next Generation Sequencing (NGS) Production Volume, Production Value and Growth Rate of NGS Pre-Sequencing (2018-2029)

      • 1.4.3 China Clinical Oncology Next Generation Sequencing (NGS) Production Volume, Production Value and Growth Rate of NGS Data Analysis (2018-2029)

      • 1.4.4 China Clinical Oncology Next Generation Sequencing (NGS) Production Volume, Production Value and Growth Rate of Primary, Secondary & Tertiary Data Analysis (2018-2029)

    • 1.5 China Clinical Oncology Next Generation Sequencing (NGS) Market Analysis by Application from Consumption End

      • 1.5.1 China Clinical Oncology Next Generation Sequencing (NGS) Sales Volume, Sales Value and Growth Rate of Pharma & Biotech Entities (2018-2029)

      • 1.5.2 China Clinical Oncology Next Generation Sequencing (NGS) Sales Volume, Sales Value and Growth Rate of Hospitals & Clinics (2018-2029)

      • 1.5.3 China Clinical Oncology Next Generation Sequencing (NGS) Sales Volume, Sales Value and Growth Rate of Academic & Clinical Research (2018-2029)

    • 1.6 China Clinical Oncology Next Generation Sequencing (NGS) Market Analysis by Region

      • 1.6.1 North China Clinical Oncology Next Generation Sequencing (NGS) Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Clinical Oncology Next Generation Sequencing (NGS) Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Clinical Oncology Next Generation Sequencing (NGS) Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Clinical Oncology Next Generation Sequencing (NGS) Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Clinical Oncology Next Generation Sequencing (NGS) Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Clinical Oncology Next Generation Sequencing (NGS) Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Clinical Oncology Next Generation Sequencing (NGS) Market Size and Growth Rate from 2018-2029

    Chapter 2 China Clinical Oncology Next Generation Sequencing (NGS) Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Clinical Oncology Next Generation Sequencing (NGS) Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Clinical Oncology Next Generation Sequencing (NGS) Market Status and Competition Analysis in 2023

      • 2.2.3 China Clinical Oncology Next Generation Sequencing (NGS) Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Clinical Oncology Next Generation Sequencing (NGS) Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Clinical Oncology Next Generation Sequencing (NGS) Industry Development

    Chapter 3 Clinical Oncology Next Generation Sequencing (NGS)Industry Chain Analysis

    • 3.1 Clinical Oncology Next Generation Sequencing (NGS) Industry Chain

    • 3.2 Clinical Oncology Next Generation Sequencing (NGS) Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Clinical Oncology Next Generation Sequencing (NGS) Market

    • 3.3 Clinical Oncology Next Generation Sequencing (NGS) Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Clinical Oncology Next Generation Sequencing (NGS) Market

    Chapter 4 China Clinical Oncology Next Generation Sequencing (NGS) Market, by Type

    • 4.1 China Clinical Oncology Next Generation Sequencing (NGS) Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Clinical Oncology Next Generation Sequencing (NGS) Total Production Volume and Growth Rate from Production Side

    • 4.5 China Clinical Oncology Next Generation Sequencing (NGS) Production Volume and Growth Rate, by Type

      • 4.5.1 China Clinical Oncology Next Generation Sequencing (NGS) Production Volume and Growth Rate of Sequencing

      • 4.5.2 China Clinical Oncology Next Generation Sequencing (NGS) Production Volume and Growth Rate of NGS Pre-Sequencing

      • 4.5.3 China Clinical Oncology Next Generation Sequencing (NGS) Production Volume and Growth Rate of NGS Data Analysis

      • 4.5.4 China Clinical Oncology Next Generation Sequencing (NGS) Production Volume and Growth Rate of Primary, Secondary & Tertiary Data Analysis

    Chapter 5 China Clinical Oncology Next Generation Sequencing (NGS) Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Clinical Oncology Next Generation Sequencing (NGS) Total Market Size and Growth Rate from Consumption End

    • 5.5 China Clinical Oncology Next Generation Sequencing (NGS) Market Size and Growth Rate, by Application

      • 5.5.1 China Clinical Oncology Next Generation Sequencing (NGS) Market Size and Growth Rate of Pharma & Biotech Entities

      • 5.5.2 China Clinical Oncology Next Generation Sequencing (NGS) Market Size and Growth Rate of Hospitals & Clinics

      • 5.5.3 China Clinical Oncology Next Generation Sequencing (NGS) Market Size and Growth Rate of Academic & Clinical Research

    Chapter 6 China Clinical Oncology Next Generation Sequencing (NGS) Market, by Region

    • 6.1 China Clinical Oncology Next Generation Sequencing (NGS) Production Volume and Production Value, by Region

    • 6.2 China Clinical Oncology Next Generation Sequencing (NGS) Sales Volume and Sales Value, by Region

    Chapter 7 North China Clinical Oncology Next Generation Sequencing (NGS) Market Analysis

    • 7.1 North China Clinical Oncology Next Generation Sequencing (NGS) Market, by Type

    • 7.2 North China Clinical Oncology Next Generation Sequencing (NGS) Market, by Application

    Chapter 8 Central China Clinical Oncology Next Generation Sequencing (NGS) Market Analysis

    • 8.1 Central China Clinical Oncology Next Generation Sequencing (NGS) Market, by Type

    • 8.2 Central China Clinical Oncology Next Generation Sequencing (NGS) Market, by Application

    Chapter 9 South China Clinical Oncology Next Generation Sequencing (NGS) Market Analysis

    • 9.1 South China Clinical Oncology Next Generation Sequencing (NGS) Market, by Type

    • 9.2 South China Clinical Oncology Next Generation Sequencing (NGS) Market, by Application

    Chapter 10 East China Clinical Oncology Next Generation Sequencing (NGS) Market Analysis

    • 10.1 East China Clinical Oncology Next Generation Sequencing (NGS) Market, by Type

    • 10.2 East China Clinical Oncology Next Generation Sequencing (NGS) Market, by Application

    Chapter 11 Northeast China Clinical Oncology Next Generation Sequencing (NGS) Market Analysis

    • 11.1 Northeast China Clinical Oncology Next Generation Sequencing (NGS) Market, by Type

    • 11.2 Northeast China Clinical Oncology Next Generation Sequencing (NGS) Market, by Application

    Chapter 12 Southwest China Clinical Oncology Next Generation Sequencing (NGS) Market Analysis

    • 12.1 Southwest China Clinical Oncology Next Generation Sequencing (NGS) Market, by Type

    • 12.2 Southwest China Clinical Oncology Next Generation Sequencing (NGS) Market, by Application

    Chapter 13 Northwest China Clinical Oncology Next Generation Sequencing (NGS) Market Analysis

    • 13.1 Northwest China Clinical Oncology Next Generation Sequencing (NGS) Market, by Type

    • 13.2 Northwest China Clinical Oncology Next Generation Sequencing (NGS) Market, by Application

    Chapter 14 Company Profiles

      • 14.1 DNASTAR

        • 14.1.1 DNASTAR Company Profile

        • 14.1.2 DNASTAR Clinical Oncology Next Generation Sequencing (NGS) Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Genomatix Software

        • 14.2.1 Genomatix Software Company Profile

        • 14.2.2 Genomatix Software Clinical Oncology Next Generation Sequencing (NGS) Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 BGI

        • 14.3.1 BGI Company Profile

        • 14.3.2 BGI Clinical Oncology Next Generation Sequencing (NGS) Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Roche

        • 14.4.1 Roche Company Profile

        • 14.4.2 Roche Clinical Oncology Next Generation Sequencing (NGS) Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Paradigm

        • 14.5.1 Paradigm Company Profile

        • 14.5.2 Paradigm Clinical Oncology Next Generation Sequencing (NGS) Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Qiagen

        • 14.6.1 Qiagen Company Profile

        • 14.6.2 Qiagen Clinical Oncology Next Generation Sequencing (NGS) Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Myriad Genetics

        • 14.7.1 Myriad Genetics Company Profile

        • 14.7.2 Myriad Genetics Clinical Oncology Next Generation Sequencing (NGS) Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Foundation Medicine

        • 14.8.1 Foundation Medicine Company Profile

        • 14.8.2 Foundation Medicine Clinical Oncology Next Generation Sequencing (NGS) Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 Biomatters

        • 14.9.1 Biomatters Company Profile

        • 14.9.2 Biomatters Clinical Oncology Next Generation Sequencing (NGS) Market Performance

        • 14.9.3 Product&Service Introduction

      • 14.10 GATC Biotech

        • 14.10.1 GATC Biotech Company Profile

        • 14.10.2 GATC Biotech Clinical Oncology Next Generation Sequencing (NGS) Market Performance

        • 14.10.3 Product&Service Introduction

      • 14.11 CLC Bio

        • 14.11.1 CLC Bio Company Profile

        • 14.11.2 CLC Bio Clinical Oncology Next Generation Sequencing (NGS) Market Performance

        • 14.11.3 Product&Service Introduction

      • 14.12 Caris Life Sciences

        • 14.12.1 Caris Life Sciences Company Profile

        • 14.12.2 Caris Life Sciences Clinical Oncology Next Generation Sequencing (NGS) Market Performance

        • 14.12.3 Product&Service Introduction

      • 14.13 Oxford Nanopore Technologies

        • 14.13.1 Oxford Nanopore Technologies Company Profile

        • 14.13.2 Oxford Nanopore Technologies Clinical Oncology Next Generation Sequencing (NGS) Market Performance

        • 14.13.3 Product&Service Introduction

      • 14.14 Agilent Technologies

        • 14.14.1 Agilent Technologies Company Profile

        • 14.14.2 Agilent Technologies Clinical Oncology Next Generation Sequencing (NGS) Market Performance

        • 14.14.3 Product&Service Introduction

      • 14.15 Knome

        • 14.15.1 Knome Company Profile

        • 14.15.2 Knome Clinical Oncology Next Generation Sequencing (NGS) Market Performance

        • 14.15.3 Product&Service Introduction

      • 14.16 Exosome Diagnostics

        • 14.16.1 Exosome Diagnostics Company Profile

        • 14.16.2 Exosome Diagnostics Clinical Oncology Next Generation Sequencing (NGS) Market Performance

        • 14.16.3 Product&Service Introduction

      • 14.17 Perkin Elmer

        • 14.17.1 Perkin Elmer Company Profile

        • 14.17.2 Perkin Elmer Clinical Oncology Next Generation Sequencing (NGS) Market Performance

        • 14.17.3 Product&Service Introduction

      • 14.18 Life Technologies

        • 14.18.1 Life Technologies Company Profile

        • 14.18.2 Life Technologies Clinical Oncology Next Generation Sequencing (NGS) Market Performance

        • 14.18.3 Product&Service Introduction

      • 14.19 Illumina

        • 14.19.1 Illumina Company Profile

        • 14.19.2 Illumina Clinical Oncology Next Generation Sequencing (NGS) Market Performance

        • 14.19.3 Product&Service Introduction

      • 14.20 Pacific Bioscience

        • 14.20.1 Pacific Bioscience Company Profile

        • 14.20.2 Pacific Bioscience Clinical Oncology Next Generation Sequencing (NGS) Market Performance

        • 14.20.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Clinical Oncology Next Generation Sequencing (NGS) Industry Research Conclusions

    • 15.2 Clinical Oncology Next Generation Sequencing (NGS) Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Clinical Oncology Next Generation Sequencing (NGS) Industry Market Size (2018-2029)

    • Figure China Clinical Oncology Next Generation Sequencing (NGS) Production Volume, Production Value and Growth Rate of Sequencing (2018-2029)

    • Figure China Clinical Oncology Next Generation Sequencing (NGS) Production Volume, Production Value and Growth Rate of NGS Pre-Sequencing (2018-2029)

    • Figure China Clinical Oncology Next Generation Sequencing (NGS) Production Volume, Production Value and Growth Rate of NGS Data Analysis (2018-2029)

    • Figure China Clinical Oncology Next Generation Sequencing (NGS) Production Volume, Production Value and Growth Rate of Primary, Secondary & Tertiary Data Analysis (2018-2029)

    • Figure China Clinical Oncology Next Generation Sequencing (NGS) Sales Volume, Sales Value and Growth Rate of Pharma & Biotech Entities (2018-2029)

    • Figure China Clinical Oncology Next Generation Sequencing (NGS) Sales Volume, Sales Value and Growth Rate of Hospitals & Clinics (2018-2029)

    • Figure China Clinical Oncology Next Generation Sequencing (NGS) Sales Volume, Sales Value and Growth Rate of Academic & Clinical Research (2018-2029)

    • Figure North China Clinical Oncology Next Generation Sequencing (NGS) Market Size and Growth Rate from 2018-2029

    • Figure Central China Clinical Oncology Next Generation Sequencing (NGS) Market Size and Growth Rate from 2018-2029

    • Figure South China Clinical Oncology Next Generation Sequencing (NGS) Market Size and Growth Rate from 2018-2029

    • Figure East China Clinical Oncology Next Generation Sequencing (NGS) Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Clinical Oncology Next Generation Sequencing (NGS) Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Clinical Oncology Next Generation Sequencing (NGS) Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Clinical Oncology Next Generation Sequencing (NGS) Market Size and Growth Rate from 2018-2029

    • Figure Clinical Oncology Next Generation Sequencing (NGS) Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Clinical Oncology Next Generation Sequencing (NGS) Market Share by Type in 2018

    • Figure China Clinical Oncology Next Generation Sequencing (NGS) Market Share by Type in 2023

    • Figure China Clinical Oncology Next Generation Sequencing (NGS) Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Clinical Oncology Next Generation Sequencing (NGS) Production Volume and Growth Rate of Sequencing (2018-2023)

    • Figure China Clinical Oncology Next Generation Sequencing (NGS) Production Volume and Growth Rate of NGS Pre-Sequencing (2018-2023)

    • Figure China Clinical Oncology Next Generation Sequencing (NGS) Production Volume and Growth Rate of NGS Data Analysis (2018-2023)

    • Figure China Clinical Oncology Next Generation Sequencing (NGS) Production Volume and Growth Rate of Primary, Secondary & Tertiary Data Analysis (2018-2023)

    • Figure China Clinical Oncology Next Generation Sequencing (NGS) Market Share by Application in 2018

    • Figure China Clinical Oncology Next Generation Sequencing (NGS) Market Share by Application in 2023

    • Figure China Clinical Oncology Next Generation Sequencing (NGS) Total Market Size and Growth Rate from Consumption End

    • Figure China Clinical Oncology Next Generation Sequencing (NGS) Market Size and Growth Rate of Pharma & Biotech Entities (2018-2023)

    • Figure China Clinical Oncology Next Generation Sequencing (NGS) Market Size and Growth Rate of Hospitals & Clinics (2018-2023)

    • Figure China Clinical Oncology Next Generation Sequencing (NGS) Market Size and Growth Rate of Academic & Clinical Research (2018-2023)

    • Table China Clinical Oncology Next Generation Sequencing (NGS) Production Volume by Region (2018-2023)

    • Table China Clinical Oncology Next Generation Sequencing (NGS) Production Volume Share by Region (2018-2023)

    • Figure China Clinical Oncology Next Generation Sequencing (NGS) Production Volume Share by Region (2018-2023)

    • Table China Clinical Oncology Next Generation Sequencing (NGS) Production Value by Region (2018-2023)

    • Table China Clinical Oncology Next Generation Sequencing (NGS) Production Value Share by Region (2018-2023)

    • Figure China Clinical Oncology Next Generation Sequencing (NGS) Production Value Share by Region (2018-2023)

    • Table China Clinical Oncology Next Generation Sequencing (NGS) Sales Volume by Region (2018-2023)

    • Table China Clinical Oncology Next Generation Sequencing (NGS) Sales Volume Share by Region (2018-2023)

    • Figure China Clinical Oncology Next Generation Sequencing (NGS) Sales Volume Share by Region (2018-2023)

    • Table China Clinical Oncology Next Generation Sequencing (NGS) Sales Value by Region (2018-2023)

    • Table China Clinical Oncology Next Generation Sequencing (NGS) Sales Value Share by Region (2018-2023)

    • Figure China Clinical Oncology Next Generation Sequencing (NGS) Sales Value Share by Region (2018-2023)

    • Table North China Clinical Oncology Next Generation Sequencing (NGS) Production Volume by Type (2018-2023)

    • Table North China Clinical Oncology Next Generation Sequencing (NGS) Production Volume Share by Type (2018-2023)

    • Figure North China Clinical Oncology Next Generation Sequencing (NGS) Production Volume Share by Type (2018-2023)

    • Table North China Clinical Oncology Next Generation Sequencing (NGS) Sales Volume by Application (2018-2023)

    • Table North China Clinical Oncology Next Generation Sequencing (NGS) Sales Volume Share by Application (2018-2023)

    • Figure North China Clinical Oncology Next Generation Sequencing (NGS) Sales Volume Share by Application (2018-2023)

    • Table Central China Clinical Oncology Next Generation Sequencing (NGS) Production Volume by Type (2018-2023)

    • Table Central China Clinical Oncology Next Generation Sequencing (NGS) Production Volume Share by Type (2018-2023)

    • Figure Central China Clinical Oncology Next Generation Sequencing (NGS) Production Volume Share by Type (2018-2023)

    • Table Central China Clinical Oncology Next Generation Sequencing (NGS) Sales Volume by Application (2018-2023)

    • Table Central China Clinical Oncology Next Generation Sequencing (NGS) Sales Volume Share by Application (2018-2023)

    • Figure Central China Clinical Oncology Next Generation Sequencing (NGS) Sales Volume Share by Application (2018-2023)

    • Table South China Clinical Oncology Next Generation Sequencing (NGS) Production Volume by Type (2018-2023)

    • Table South China Clinical Oncology Next Generation Sequencing (NGS) Production Volume Share by Type (2018-2023)

    • Figure South China Clinical Oncology Next Generation Sequencing (NGS) Production Volume Share by Type (2018-2023)

    • Table South China Clinical Oncology Next Generation Sequencing (NGS) Sales Volume by Application (2018-2023)

    • Table South China Clinical Oncology Next Generation Sequencing (NGS) Sales Volume Share by Application (2018-2023)

    • Figure South China Clinical Oncology Next Generation Sequencing (NGS) Sales Volume Share by Application (2018-2023)

    • Table East China Clinical Oncology Next Generation Sequencing (NGS) Production Volume by Type (2018-2023)

    • Table East China Clinical Oncology Next Generation Sequencing (NGS) Production Volume Share by Type (2018-2023)

    • Figure East China Clinical Oncology Next Generation Sequencing (NGS) Production Volume Share by Type (2018-2023)

    • Table East China Clinical Oncology Next Generation Sequencing (NGS) Sales Volume by Application (2018-2023)

    • Table East China Clinical Oncology Next Generation Sequencing (NGS) Sales Volume Share by Application (2018-2023)

    • Figure East China Clinical Oncology Next Generation Sequencing (NGS) Sales Volume Share by Application (2018-2023)

    • Table Northeast China Clinical Oncology Next Generation Sequencing (NGS) Production Volume by Type (2018-2023)

    • Table Northeast China Clinical Oncology Next Generation Sequencing (NGS) Production Volume Share by Type (2018-2023)

    • Figure Northeast China Clinical Oncology Next Generation Sequencing (NGS) Production Volume Share by Type (2018-2023)

    • Table Northeast China Clinical Oncology Next Generation Sequencing (NGS) Sales Volume by Application (2018-2023)

    • Table Northeast China Clinical Oncology Next Generation Sequencing (NGS) Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Clinical Oncology Next Generation Sequencing (NGS) Sales Volume Share by Application (2018-2023)

    • Table Southwest China Clinical Oncology Next Generation Sequencing (NGS) Production Volume by Type (2018-2023)

    • Table Southwest China Clinical Oncology Next Generation Sequencing (NGS) Production Volume Share by Type (2018-2023)

    • Figure Southwest China Clinical Oncology Next Generation Sequencing (NGS) Production Volume Share by Type (2018-2023)

    • Table Southwest China Clinical Oncology Next Generation Sequencing (NGS) Sales Volume by Application (2018-2023)

    • Table Southwest China Clinical Oncology Next Generation Sequencing (NGS) Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Clinical Oncology Next Generation Sequencing (NGS) Sales Volume Share by Application (2018-2023)

    • Table Northwest China Clinical Oncology Next Generation Sequencing (NGS) Production Volume by Type (2018-2023)

    • Table Northwest China Clinical Oncology Next Generation Sequencing (NGS) Production Volume Share by Type (2018-2023)

    • Figure Northwest China Clinical Oncology Next Generation Sequencing (NGS) Production Volume Share by Type (2018-2023)

    • Table Northwest China Clinical Oncology Next Generation Sequencing (NGS) Sales Volume by Application (2018-2023)

    • Table Northwest China Clinical Oncology Next Generation Sequencing (NGS) Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Clinical Oncology Next Generation Sequencing (NGS) Sales Volume Share by Application (2018-2023)

    • Table DNASTAR Company Profile

    • Table DNASTAR Clinical Oncology Next Generation Sequencing (NGS) Revenue, Price and Gross (2018-2023)

    • Table Genomatix Software Company Profile

    • Table Genomatix Software Clinical Oncology Next Generation Sequencing (NGS) Revenue, Price and Gross (2018-2023)

    • Table BGI Company Profile

    • Table BGI Clinical Oncology Next Generation Sequencing (NGS) Revenue, Price and Gross (2018-2023)

    • Table Roche Company Profile

    • Table Roche Clinical Oncology Next Generation Sequencing (NGS) Revenue, Price and Gross (2018-2023)

    • Table Paradigm Company Profile

    • Table Paradigm Clinical Oncology Next Generation Sequencing (NGS) Revenue, Price and Gross (2018-2023)

    • Table Qiagen Company Profile

    • Table Qiagen Clinical Oncology Next Generation Sequencing (NGS) Revenue, Price and Gross (2018-2023)

    • Table Myriad Genetics Company Profile

    • Table Myriad Genetics Clinical Oncology Next Generation Sequencing (NGS) Revenue, Price and Gross (2018-2023)

    • Table Foundation Medicine Company Profile

    • Table Foundation Medicine Clinical Oncology Next Generation Sequencing (NGS) Revenue, Price and Gross (2018-2023)

    • Table Biomatters Company Profile

    • Table Biomatters Clinical Oncology Next Generation Sequencing (NGS) Revenue, Price and Gross (2018-2023)

    • Table GATC Biotech Company Profile

    • Table GATC Biotech Clinical Oncology Next Generation Sequencing (NGS) Revenue, Price and Gross (2018-2023)

    • Table CLC Bio Company Profile

    • Table CLC Bio Clinical Oncology Next Generation Sequencing (NGS) Revenue, Price and Gross (2018-2023)

    • Table Caris Life Sciences Company Profile

    • Table Caris Life Sciences Clinical Oncology Next Generation Sequencing (NGS) Revenue, Price and Gross (2018-2023)

    • Table Oxford Nanopore Technologies Company Profile

    • Table Oxford Nanopore Technologies Clinical Oncology Next Generation Sequencing (NGS) Revenue, Price and Gross (2018-2023)

    • Table Agilent Technologies Company Profile

    • Table Agilent Technologies Clinical Oncology Next Generation Sequencing (NGS) Revenue, Price and Gross (2018-2023)

    • Table Knome Company Profile

    • Table Knome Clinical Oncology Next Generation Sequencing (NGS) Revenue, Price and Gross (2018-2023)

    • Table Exosome Diagnostics Company Profile

    • Table Exosome Diagnostics Clinical Oncology Next Generation Sequencing (NGS) Revenue, Price and Gross (2018-2023)

    • Table Perkin Elmer Company Profile

    • Table Perkin Elmer Clinical Oncology Next Generation Sequencing (NGS) Revenue, Price and Gross (2018-2023)

    • Table Life Technologies Company Profile

    • Table Life Technologies Clinical Oncology Next Generation Sequencing (NGS) Revenue, Price and Gross (2018-2023)

    • Table Illumina Company Profile

    • Table Illumina Clinical Oncology Next Generation Sequencing (NGS) Revenue, Price and Gross (2018-2023)

    • Table Pacific Bioscience Company Profile

    • Table Pacific Bioscience Clinical Oncology Next Generation Sequencing (NGS) Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US